title: Potential cost-savings may be considerable with management of hypertension according to updated US hypertension guidelines, but for women aged 35-44 years these benefits are unlikely.
authors.affiliation: Department of Medicine, Monash University, Clayton, Victoria, Australia.
authors.forename: Dominique A
authors.initials: DA
authors.lastname: Cadilhac
authors.affiliation: Department of Medicine, Monash University, Clayton, Victoria, Australia.
authors.forename: Joosup
authors.initials: J
authors.lastname: Kim
mesh_terms: D000959:Antihypertensive Agents / Q000191:economics*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D006973:Hypertension / Q000191:economics*; D008297:Male; D017410:Practice Guidelines as Topic; D019057:Quality-Adjusted Life Years
chemical_list: D000959:Antihypertensive Agents
keywords: CARDIOLOGY; HEALTH ECONOMICS; PUBLIC HEALTH